BXP enters the week with a genuinely mixed read: the stock is up 10% over the past month and 3.4% on the week, yet short interest runs at 7.1% of the free float and the options market is its most bullish in months — a setup that rewards closer inspection.
The options picture is the clearest signal of shifting sentiment. Traders have rotated sharply away from defensive hedges, with the put/call ratio dropping to 0.51 — well below its 20-day average of 0.59 and near the 52-week low of 0.42. A z-score of -0.84 confirms the move is meaningful relative to recent history. Through most of June, the PCR was running above 0.65; the shift lower tracks almost perfectly with BXP's price recovery from the mid-$50s. Options traders are no longer paying up for downside protection.
The lending market reinforces that picture — but with nuance. Borrow availability is loose, running at roughly 707% of short interest. That means about seven shares are available to borrow for every one already shorted, the highest that ratio has been in the past 52 weeks (the annual minimum availability was 263%). Cost to borrow has fallen 13% on the week to 0.44%, a level that qualifies as plainly cheap. Short interest itself dipped nearly 3% on the week to 11.3 million shares, or 7.1% of float. The one-month trend cuts the other way — SI is up about 2.3% over 30 days — but the direction of the past week, combined with loose borrow and falling costs, suggests shorts are not adding pressure into the rally. Positioning looks cautious rather than crowded.
Analyst activity has turned notably constructive. In the past two sessions alone, Ladenburg Thalmann raised its target to $80 and Evercore ISI Group nudged to $68 — both maintaining their existing ratings. Earlier in June, Scotiabank upgraded the stock to Sector Outperform and lifted its target to $70. The consensus mean target now sits at $70.20, roughly in line with the current price of $68.59, which limits near-term implied upside but reflects a street that has been steadily marking targets higher after a cluster of cuts in May. Back then, UBS, Barclays, and Cantor Fitzgerald all trimmed targets — some materially — while keeping constructive ratings, a pattern that now looks like trough pessimism. EPS surprise ranks in the 91st percentile of the ORTEX universe, and the analyst recommendation divergence factor scores at the 99th percentile, both pointing to a stock that keeps beating low expectations. The PE multiple has expanded about 2 points over 30 days to 31.6x, and the price-to-book ratio has risen 0.18 over the same period — a modest but consistent re-rating as the stock has climbed. The bear case centres on occupancy fragility in gateway markets and refinancing headwinds; bulls point to the Class A portfolio and a disposition programme that should clean up the balance sheet over time.
The institutional ownership story carries one noteworthy data point. Cohen & Steers, the largest holder with nearly 13% of shares, added over 5.4 million shares in Q1. First Eagle added 5.9 million shares through April. Both are specialist real estate investors, and both were buyers into what was then weakness — lending the recent price recovery some fundamental backing rather than purely short-covering mechanics.
The next focal point is the Q2 earnings release, scheduled for July 28. The last three prints produced muted same-day moves — a decline of roughly 1.2% on the most recent occasion, with the stock recovering within a week each time. With the ORTEX short score easing from 59.1 at end-June to 54.3 today, the borrow market loose, and the PCR near annual lows, the key question heading into July 28 is whether leasing momentum in BXP's gateway markets can give the Street the occupancy signal needed to sustain a multiple that has already expanded meaningfully.
See the live data behind this article on ORTEX.
Open BXP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
